Laffin, Luke J <br/><br/>
A data-zone scoring system to assess the generalizability of clinical trial results to individual patients.  [electronic resource] 

 -  European journal of preventive cardiology  04 2019 
 - 569-575 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2047-4881 
<br/><br/><label>Standard No.: </label>10.1177/2047487318815967  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Antihypertensive Agents--therapeutic use<br/>Biomarkers--blood<br/>Blood Glucose--metabolism<br/>Blood Pressure--drug effects<br/>Body Mass Index<br/>Cholesterol--blood<br/>Clinical Decision-Making<br/>Comorbidity<br/>Creatinine--blood<br/>Eligibility Determination<br/>Evidence-Based Medicine<br/>Female<br/>Health Status<br/>Humans<br/>Hypertension--diagnosis<br/>Male<br/>Middle Aged<br/>Nutrition Surveys<br/>Patient Selection<br/>Prospective Studies<br/>Randomized Controlled Trials as Topic<br/>Risk Factors<br/>Treatment Outcome<br/>United States--epidemiology